Abbott Laboratories must face manufacturing defect claims in a suit alleging a recalled heart pump malfunctioned and caused complications that led to a patient’s removal from the heart transplant list, a Louisiana federal court said.
But William McKenzie’s claims alleging the company didn’t adequately train doctors, didn’t timely report complications, and breached an express warranty that its Heartmate 3 was superior to other devices were dismissed, for now.
McKenzie received a Heartmate 3 on Sept. 5, 2017, while waiting for a transplant. The device reroutes and pumps blood from the left ventricle into the ascending aorta.
Abbott recalled the Heartmate ...